Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001997584-26-000002

Chief Medical Officer sold 55,000 shares at an average $19.85 ($1,091,662)

  • Chief Medical Officer acquired 55,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lechleider Robert Chief Medical Officer 2026-06-25 Option exercise 10b5-1 +55,000 $8.73 $480,150 70,805 D: show line 1 in the form
Lechleider Robert Chief Medical Officer 2026-06-25 Sale 10b5-1 −40,580 $19.56 $793,745 30,225 D: show line 2 in the form
Lechleider Robert Chief Medical Officer 2026-06-25 Sale 10b5-1 −14,420 $20.66 $297,917 15,805 D: show line 3 in the form
Open-market sales · 55,000 sh · avg $19.85 · $1,091,662

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lechleider Robert Chief Medical Officer 2026-06-25 Option exercise · Employee Stock Option (right to buy) 10b5-1 −55,000 345,000 D: show line 4 in the form
Loading xslF345X06/form4-06292026_080646.xml…